Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition

Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition

Abstract Despite novel immunotherapies being approved and established for the treatment of non-small cell lung cancer (NSCLC), ex vivo models predicting individual patients’ responses to immunotherapies are missing. Especially immune modulating therapies with moderate response rates urge for biomark...

Full description

Bibliographic Details
Main Authors: David Junk, Sebastian Krämer, Johannes Broschewitz, Hennig Laura, Chiara Massa, Yousef Moulla, Ngoc Anh Hoang, Astrid Monecke, Uwe Eichfeld, Ingo Bechmann, Florian Lordick, Barbara Seliger, Sonja Kallendrusch
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-021-00651-5

Internet

https://doi.org/10.1038/s41420-021-00651-5

Similar Items